| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| H2 Financial Management (HTWO) | EarlyBirdCapital | 14.80 | $10.00 | $10.00 | $148.00 | n.a |
| NV5 Holdings (NVEE.U)(u) | Roth Capital Partners | $6.90 | n.a | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| ConnectOne Bancorp (CNOB) | Stifel Nicolaus Weisel | 1.60 | $26.00 | $29.00 | $44.00 | n.a. |
| ExOne Company (The) (XONE) | FBR | 5.00 | $14.00 | $16.00 | $75.00 | 1-Star |
| New Source Energy Partners L.P. (NSLP) | Baird/ Stifel Nicolaus Weisel/ BMO Capital Markets/ Oppenheimer & Co. | 4.00 | $19.00 | $21.00 | $80.00 | 2-Stars |
| Pinnacle Foods (PF) | Barclays/ BofA Merrill Lynch/ Credit Suisse/ Goldman, Sachs/ Morgan Stanley/ UBS Investment Bank | $100.00 | 1-Star | |||
| TRI Pointe Homes (TPH) | Citigroup/ Deutsche Bank Securities/ FBR | 13.69 | $14.00 | $16.00 | $205.34 | 3-Stars |
| XOOM (XOOM) | Barclays/ Needham | 5.75 | $13.00 | $15.00 | $80.50 | 1-Star |
| ZAIS Financial (ZFC) | Deutsche Bank Securities/ Citigroup/ Barclays/ Credit Suisse | 5.65 | $21.25 | $21.25 | $120.06 | 1-Star |
| n.a. (not available) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Jan. 28, 2013 | Manager(s) | Offered | Raised | Price | 2/1/13 | Change |
| Zoetis (ZTS) | J.P. Morgan/ BofA Merrill Lynch/ Morgan Stanley | 86.10 | $2,238.60 | $26.00 | $31.01 | 19.27% |
| TRI Pointe Homes (TPH) | Citigroup/ Deutsche Bank Securities/ FBR | 13.69 | $232.71 | $17.00 | $19.00 | 11.76% |
| Stemline Therapeutics (STML) | Aegis Capital | 3.32 | $33.18 | $10.00 | $10.75 | 7.50% |
| Gladstone Land (LAND) | Janney Montgomery Scott/ JMP Securities | 3.33 | $50.00 | $15.00 | $15.00 | 0.00% |
| KaloBios Pharmaceuticals (KBIO) | Leerink Swann | 8.75 | $70.00 | $8.00 | $8.00 | 0.00% |
